|

Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study

RECRUITINGSponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna
Actively Recruiting
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Started2021-04-21
Est. completion2030-03
Eligibility
Age18 Years+

Summary

The goal of this observational study is to learn what are the best conditions that will give a positive outcome to men and women that receive a intra arterial therapy (IAT) for primary liver cancer. Intra arterial therapies are radiologic procedures that block liver cancer blood supply. The researchers will collect the data of participants located in the Radiology department in "IRCCS Azienda Ospedaliera Universitaria" Hospital in Bologna and will study clinic and radiological traits to understand which is the best case scenario for a optimal treatment response.

Eligibility

Age: 18 Years+
Inclusion Criteria:

* diagnosis of Hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (iCCA) and clinical indication to receive or have already received one of the following treatments:

  * Trans-arterial embolization (TAE),
  * Transarterial chemoembolization (TACE),
  * Transarterial radioembolization (TARE)
  * Drug-eluting beads chemoembolization (DEB-TACE)
* Age over 18
* To give informed consent

Exclusion Criteria:

* shunt of gastro intestinal arteries that cannot be embolized
* metastasis spread outside of the liver
* liver failure

Conditions5

CancerCholangiocarcinoma CancerHCC - Hepatocellular CarcinomaLiver CancerLiver Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.